Skip to main content
PTHS logo

PTHS · Pelthos Therapeutics Inc. · Analyst Estimates

Track PTHS — free
$20.55 +0.20 (+0.98%)
Market Cap
$84.95M
Shares
3.83M
Volume · Oct 2 7017 Avg daily vol (3M) 58.45K

Analyst Estimates

Compare analyst forecasts for Pelthos Therapeutics Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 22:56 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-27.45
-18.82
-12.4
—
-18.82
-10.6625
-18.82
-10.6625
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
2
2
0
0
Revenue
USD
Publication date not stated
55768000
63746000
72100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-7.76
-5.6825
-1.45
—
-5.6825
-2.125
-5.6825
-2.125
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
75941000
112218000
138600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-4.6
-3.34
-1.6
—
-3.34
-1.8925
-3.34
-1.8925
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
16700000
17962140
20600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-4.71
-3.12
-1.1
—
-3.12
-1.965
-3.12
-1.965
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
0
0
0
0
Revenue
USD
Publication date not stated
12225000
19195710
25000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —
Key facts CIK 1919246 CUSIP 171126204 13F (30d) 2 filings 2 filers Visit website Investor relations